Technologies for doctors to make better decisions faster
Leveraging theory, computation and experiments, my group and I are creating novel measurement and prediction systems for integrated cancer biology. We work in translational projects on three frontiers:
 |
 |
 |
| Tumour evolution | Tissue context | Interaction networks |
|
(1) Revealing the mutational processes acting on cancer genomes, measuring their impact on patient phenotypes, and using them for personalised therapy decisions; |
(2) Improved patient stratification, early detection, and prognosis by predictive modelling of tumour imaging and genomics data; |
(3) Predicting strategies to overcome resistance and reduce toxicity by comparative network analysis of transcriptional responses to combinatorial CRISPR perturbations in single cells. |
Publications
- Cmero et al (2020), SVclone: inferring structural variant cancer cell fraction, Nature Comms
- Holding et al (2019), VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer, Genome Biology
- Macintyre*, Goranova* et al (2018), Copy-number signatures and mutational processes in ovarian carcinoma, Nature Genetics
Software
- VULCAN - infer cofactors from ChIP-seq differential binding
- OncoNEM - Clonal evolution trees from single cell data
- Bitphylogeny - Bayesian framework for intra-tumour phylogenies
- MEDICC - intra-tumor copy-number comparisons
- nem - inferring Nested Effects Models from downstream perturbation effects
- RedeR - statistical computing and network visualization
